Abstract

Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted)

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2019 - Volume 23, Number 5

Page(s): 409

Download in electronic PDF format for $75
  • Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted) Page 1

Abstract

A formulation for preparing Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted). Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • omeprazole
  • formulation
  • proton pump inhibitor
  • hyperacidity
  • gastric acid
  • stability

Related Categories

  • FORMULATIONS
  • GASTROENTEROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2019
Pg. 409
Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted)
Author(s): Allen Loyd V Jr
Mar/Apr 2012
Pg. 164-166
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted)
Author(s): Whaley Paul A, Voudrie Mark A II, Sorenson Bridget
Mar/Apr 2011
Pg. 124-128
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Author(s): Corsini Lindsay, Williams LaVonn A
Jan/Feb 2019
Pg. 58
Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2020
Pg. 140-147
The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment
Author(s): Meissner Svenja, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren
Nov/Dec 2019
Pg. 504-510
Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Author(s): Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Nov/Dec 2017
Pg. 500-512
To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid
Author(s): Chuong Monica C, Taglieri Catherine A, Kerr Stephen G
May/Jun 2023
Pg. 250-255
Stability of Omeprazole Extemporaneous Oral Solution in Chopin Base
Author(s): Spennacchio Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio
Sep/Oct 2006
Pg. 389
Omeprazole 2-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 2009
Pg. 250-253
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding
Author(s): Garg Sanjay, Svirskis Darren, Al-Kabban Majid, Farhan Samer, Komeshi Mohammed, Lee Jacky, Liu Quincy, Naidoo Sacha, Kairuz Therese
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Sep/Oct 2015
Pg. 420-427
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF
Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul
Jul/Aug 2013
Pg. 344-346
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry
Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Jan/Feb 2010
Pg. 82-85
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution)
Author(s): Voudrie Mark A II, Allen D Brett
Jul/Aug 2018
Pg. 321
Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry
Author(s): Allen Loyd V Jr
Jan/Feb 2018
Pg. 56
Ranitidine 15 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 417-423
Prolonged In-use Stability of Reconstituted Herceptin in Commercial Intravenous Bags
Author(s): Nalenz Heiko, Köpf Ellen, Dietel Elke
Jul/Aug 2013
Pg. 336-338
Stability of Captopril in SyrSPend SF
Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Jul/Aug 2012
Pg. 347-349
Stability of Gabapentin in SyrSpend SF
Author(s): Sorenson Bridget, Voudrie Mark A II, Gehrig Dan